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182 FUNCTIONAL TOLL-LIKE AND NOD-LIKE RECEPTORS IN
HUMAN ARTICULAR CHONDROCYTES
M.A. Pratta, F. Wang, T.M. Newman-Tarr, S. Hwang, B.J. Votta,
S. Kumar, M.K. Majumdar. GlaxoSmithKline Pharmaceutical Co.,
Collegeville, PA, USA
Purpose: Investigate the potential involvement of pattern recognition
receptors (PRRs) such as cytosolic nod-like receptors (NLRs) and
membrane-associated toll-like receptors (TLRs) in OA.
Methods: Human articular cartilage was obtained with informed consent
and was used under the approval of the institutional review board (IRB).
Cartilage explants were incubated with LPS, MDP, iE-DAP, or their re-
spective controls for up to 10 days, and conditioned media was removed
and replaced with fresh treatments every 1−4 days. Media was analyzed
for total aggrecan degradation based on glycosaminoglycan (GAG) levels
using the DMMB colorimetric assay, and for ARGSVIl-aggrecan content
by Western analysis. To measure induction of aggrecanase, isolated
human articular chondrocytes were grown on a streptaviden-coated 96-
well plate containing an immobilized aggrecanase peptide substrate.
Induction of aggrecanase resulted in speciﬁc cleavage of the peptide
substrate that is detected by a highly sensitive, speciﬁc monoclonal
antibody in an ELISA. Monolayer chondrocytes and articular cartilage
were also used to examine the effects on gene expression by Q-PCR
and cytokines/chemokine levels were determined by Bioplex.
Results: LPS induced aggrecanase activity in a chondrocyte-cell based
assay, and this activity was blocked by a broad spectrum Aggrecanase
inhibitor. Interestingly, this activity, as well as LPS-induced nitric oxide
and cytokine/chemokine production, was inhibited by TLR antagonist
CRX-526. LPS also induced aggrecanase activity in human cartilage
explants as measured by an increase in aggrecan fragments carrying
the N-terminal ARGSVIl-neoepitope, and CRX-526 was able to block
generation of these fragments induced by LPS. These data support a
role of TLRs in the induction of aggrecanases by LPS. CRX-526 was
not effective in blocking aggrecanase induction by Il-1 and OSM, nor the
generation of ARGSVIl-aggrecan fragments in the absence of stimulus in
human cartilage explants, suggesting that these pathways do not involve
TLRs. Since LPS may also induce cytokines that result in the induction
of the aggrecanases, these data suggest that the TLR contribution is
‘upstream’ of cytokine induction of proteolytic enzymes by LPS.
The effect of the classical NLR ligands, iE-DAP (NOD-1) and MDP
(NOD-2, NLRP3, etc) was also evaluated in this system. Only MDP was
effective in inducing a concentration-dependent induction of aggrecanase
activity that appeared to reach a plateau between 1−10ug/ml. MDP was
also effective in inducing aggrecanase-mediated aggrecan degradation
based on the production of the ARGSVIl-neoepitope. Gene expression
analysis demonstrated the expression of several NLRs in chondrocytes,
including NOD-1, NOD-2, NLR-3, suggesting a potential role of these
NLRs in OA
Conclusions: These data suggest that aggrecanase activity and aggre-
can degradation are inducible by ligands of both TLR and NLR pathways,
and suggest that these receptors may be involved in cartilage degradation
in OA. The observation that a TLR-2,4 antagonist was effective in blocking
aggrecanase-mediated aggrecan degradation suggests that modulation
of these pathways may have therapeutic utility in the treatment of OA.
183 HISTONE DEACETYLASE INHIBITORS SUPPRESS
INTERLEUKIN-1b-INDUCED MPGES-1 EXPRESSION IN
HUMAN CHONDROCYTES
N. CHABANE, H. Aﬁf, N. Zayed, J. Martel-Pelletier, J-P. Pelletier,
H. Fahmi. Centre Hospitalier de l’Universite´ de Montre´al, Montreal, QC,
CANADA
Purpose: Microsomal prostaglandin E synthase-1 (mPGES-1), catalyzes
the terminal step in the biosynthesis of PGE2, which plays an important
role in the pathogenesis of osteoarthritis (OA). In the present study,
we determined the effect of trichostatin A (TSA), butyric acid (BA), and
valproic acid (VA), three histone deacetylase (HDAC) inhibitors, on Il-1-
induced mPGES-1 protein and mRNA expression in human chondro-
cytes. We also investigated the expression and DNA binding activity of
Egr-1, a key transcription factor in mPGES-1 expression.
Methods: Chondrocytes were stimulated with Il-1 in the absence or
presence of increasing concentrations of TSA, BA or VA. The expression
of mPGES-1 protein and mRNA were evaluated using Western blotting
and real-time reverse transcriptase-polymerase chain reaction (RT-PCR),
respectively. Electrophoretic mobility shift assay (EMSA) was utilized to
analyze the DNA binding activity of Egr-1.
Results: TSA, BA and VA prevented Il-1-induced mPGES-1 protein and
mRNA expression, implying that a deacetylase activity is required for the
induction of mPGES-1 expression. Furthermore, we demonstrated that
the induction of Egr-1 expression and it DNA binding activity by Il-1 were
not impaired upon treatment with histone deacetylase inhibitors.
Conclusions: These data indicate that HDAC inhibition prevents Il-1-
induced mPGES-1 expression without interfering with Egr-1 expression
or DNA-binding activity. They also suggest that HDAC inhibitors could be
of potential interest in the treatment of OA.
184 INTERLEUKIN-4/INTERLEUKIN-4 RECEPTOR SYSTEM
ACTIVITY IN OSTEOARTHRITIC CHONDROCYTES
P. Dolzani1, E. Olivotto1, E. Assirelli1, S. Pagani1, L. Pulsatelli1,
R.M. Borzı`1, A. Facchini2, F. Flamigni2, A. Facchini3, R. Meliconi3.
1Istituto Ortopedico Rizzoli, Bologna, ITALY , 2Dipartimento di
Biochimica, University of Bologna, Bologna, ITALY, 3University of
Bologna, Istituto Ortopedico Rizzoli, Bologna, ITALY
Purpose: In osteoarthritis (OA), the ﬁnal result of chondrocyte
metabolic modiﬁcation is the enhancement of cartilage matrix catabolism,
not adequately counterbalanced by anabolic events. Interleukin-4
(Il-4)/interleukin-4 receptor (Il-4R) system has a pivotal role in chondro-
cyte anabolic response to mechanical stimulation which in turn is an
essential condition to maintain cartilage homeostasis. Previous studies
reported a modiﬁcation of mechanotrasduction response in OA chondro-
cytes suggesting an impaired efﬁcacy of the Il-4/Il-4R system protective
effect and underline the importance of disordered mechanical signalling
in cartilage breakdown pathways.
We aim to investigate chondrocyte response induced by Il-4/Il-4R sys-
tem, focusing on modulation of peculiar pathways involved in cartilage
breakdown.
Methods: Articular cartilage specimens were obtained from OA patients
undergoing joint replacement surgery. Chondrocytes were isolated from
articular cartilage by sequential enzymatic digestion. Chondrocyte micro-
mass and hyperconﬂuent cultures were set up with Il-4 alone or with pro-
inﬂammatory (Il-1) and anti-inﬂammatory cytokines (Il-13). Culture super-
natants were analysed for chemokines production, CXCL8 (Il-8), CXCL1
(GROalpha), CCL5 (RANTES), by enzyme-linked immuno-sorbent assay
(ELISA). RNA were extracted from chondrocytes cultured in described
conditions and real time PCR analysis were performed. mRNA ex-
pression of chemokines (Il-8, GRO alpha, RANTES), matrix degrading
enzymes (metalloprotease-13/MMP-13, aggrecanases ADAMTS-4 and
ADAMTS-5) and tissue inhibitors of metalloproteinases (TIMP-1, -3, -4)
were investigated.
Results: Data obtained from ELISA quantiﬁcation of chemokine produc-
tion by OA chondrocyte cultures showed that Il-4 presence signiﬁcantly
inhibits RANTES release induced by Il-1. On the other hand, Il-4 did not
affect GROalpha and Il-8 production induced by Il-1. These data were
also conﬁrmed by overlapping pattern of chemokine mRNA expression.
mRNA modulation analysis of matrix degrading enzymes and their in-
hibitors shows that Il-4 down modulated also MMP-13, ADAMTS-4, -5 and
TIMP-1, -3 mRNA expression induced by Il-1. On the contrary, TIMP-4
mRNA expression appears to be inhibited by Il-1 and strongly induced by
Il-4.
Conclusions: These data underline the complexity of Il-4/Il-4R activity
and suggest the involvement of multiple signal transduction pathways
of cellular response. Actually, preliminary results suggest that Il-4 can
selectively inhibit nuclear translocation of some members of the NF-úB
transcription factor family.
185 PROSTAGLANDIN D2 INHIBITS INTERLEUKIN-1-b-INDUCED
MATRIX METALLOPROTEINASE-1 AND -13 PRODUCTION BY
HUMAN CHONDROCYTES VIA ITS DP1 RECEPTOR AND
CAMP/PKA PATHWAY
N. Zayed, H. Aﬁf, N. Chabane, J. Martel-Pelletier, J-P. Pelletier,
H. Fahmi. Centre Hospitalier de l’Universite´ de Montre´al, Montreal, QC,
CANADA
Purpose: To investigate the effects of prostaglandin (PG) D2 on
interleukin-1b (Il-1)-induced matrix metalloproteinase (MMP)-1 and MMP-
13 expression in human chondrocytes and the intracellular signalling
pathways involved in the effects of PGD2.
Methods: Chondrocytes were stimulated with Il-1±PGD2 and MMP-1
and MMP-13 protein expression was evaluated by ELISA. mRNA ex-
pression and promoter activity were analyzed by real-time RT-PCR and
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transient transfection experiments, respectively. The role of the PGD2
receptors, D prostanoid receptor 1 (DP1) and chemoattractant-receptor-
like molecule expressed on Th2 cells (CRTH2), was evaluated using
speciﬁc agonists and antibody blocking experiments. The contribution of
the cAMP/PKA pathway was determined using cAMP elevating agents
and PKA inhibitors.
Results: PGD2 dose-dependently decreased Il-1-induced MMP-1 and
MMP-13 protein and mRNA expression as well as MMP-1 and -13
promoter activation. DP1 and CRTH2 are expressed and functional in
chondrocytes. The effect of PGD2 was mimicked by the selective DP1
agonist BW245C, but not by the CRTH2 selective agonist DK-PGD2.
Furthermore, treatment with an anti-DP1 antibody reversed the effect of
PGD2, indicating that the inhibitory effect of PGD2 is mediated by DP1.
The cAMP elevating agents, 8-Br-cAMP and forskolin, suppressed Il-1-
induced MMP-1 and MMP-13 expression, and the PKA inhibitors, KT5720
and H-89, reversed the inhibitory effect of PGD2, suggesting that the
effect of PGD2 is mediated by the cAMP/PKA pathway.
Conclusions: PGD2 inhibits Il-1-induced MMP-1 and MMP-13 production
by chondrocytes through the DP1/cAMP/PKA signalling pathway. This
suggest that modulation of PGD2 levels in the joint may have therapeutic
potential in the prevention of cartilage degradation.
186 “EX VIVO” ANALYSIS OF THE FIRST DOWNSTREAM
EVENTS OF TGF-b SIGNALING IN HUMAN OSTEOARTHRITIC
CARTILAGE
M. Pombo-Suarez1, M. Castan˜o-Oreja2, J.J. Gomez-Reino1,
A. Gonzalez1. 1Hospital Clinico Universitario de Santiago, Santiago
de Compostela, SPAIN, 2Universidad de Santiago de Compostela,
Santiago de Compostela, SPAIN
Purpose: Some TGF-beta family members are critical players in cartilage
homeostasis and repair. They act through phosphorylation of R-SMADs
leading to activation of a series of downstream events. The precise
regulation of SMADs remains unclear with the participation of both tran-
scriptional and posttranslational mechanisms. The recent identiﬁcation of
a phosphatase, PPM1A, which speciﬁcally acts on SMADs has provided
clues to understand termination of TGF-beta signaling. We aimed to study
for the ﬁrst time PPM1A in cartilage together with SMAD-2 and -3, the
two SMADs that are phosphorylated in response to TGF-beta.
Methods: Cartilage samples were obtained from 11 patients with hip
OA and 11 patients with femoral neck fracture that were undergoing
total hip replacement. Gene expression of PPM1A, SMAD2 and SMAD3
was analyzed by RT-qPCR. Immunohistochemistry of the three proteins
encoded by these genes and of the phosphorylated forms of Smad2 and
Smad3 was performed.
Results: PPM1A was found to be expressed in both, OA and control hu-
man cartilage. SMAD2 expression was slightly increased in OA cartilage
(p = 0.04) in relation with control cartilage, whereas no signiﬁcant differ-
ence was found in PPM1A and SMAD3. No signiﬁcant correlation was
found between the expression of any of the three molecules. Preliminary
immunostaining results showed no marked differences between OA and
control cartilage.
Conclusions: Demonstration of PPM1A in human cartilage indicates that
this phosphatase is also involved in TGF-beta signal regulation in this
tissue. However, it was not differentially regulated in OA. SMAD2 expres-
sion was slightly higher in OA than in control cartilage indicating the need
to study its regulation and suggesting the possibility of enhanced TGF-
beta downstream signaling in OA. However, a more extensive analysis of
Smad2 and Smad3 phosphorylation should be done before reaching a
sound conclusion.
187 INTRACELLULAR OXIDANT PRODUCTION BY
CHONDROCYTES IN OSTEOCHONDRAL EXPLANTS
FOLLOWING BLUNT IMPACT INJURY
D.J. McCabe, N.J. Stroud, P.S. Ramakrishnan, J.A. Buckwalter IV,
D.R. Pedersen, J.A. Martin. University of Iowa, Iowa City, IA, USA
Purpose: Acute chondrocyte necrosis and apoptosis induced by mechan-
ical injury to articular cartilage is thought to contribute to the pathogenesis
of post-traumatic osteoarthritis (PTOA). Ongoing work in our laboratory
indicated that injury-induced chondrocyte death could be signiﬁcantly
inhibited by the free radical scavenger n-acetyl cysteine (NAC). This
ﬁnding suggested that damaging levels of reactive oxygen species (ROS)
were produced by chondrocytes in response to mechanical injury. An
in vitro cartilage injury model was used to test this hypothesis. Os-
teochondral explants injured by high-energy blunt impact loading were
stained with dihydroethidium (DHE) to probe for superoxide production
by chondrocytes. Intracellular oxidation of DHE resulting in the accumu-
lation of ethidium in oxidant-producing cells was monitored by confocal
microscopy. Further support was provided by an NADPH-oxidase (NOX)
inhibitor, which reduced chondrocyte death post-blunt impact.
Methods: To simulate cartilage injuries sustained in vivo as a result of
blunt trauma we subjected bovine osteochondral explants to a single
blunt impact blow (2.5 or 5 J) via a 5mm diameter platen using a drop
tower device. Imaging of superoxide production was accomplished by
incubating the explants in complete medium (DMEM, F-12, 10% Fetal
Bovine Serum) equilibrated in low oxygen conditions with 5 mM DHE.
Figure 1. Time course of post-impact chondrocyte death and NAC effects.
Superﬁcial viability of chondrocytes. A illustrates the differences in viability
across time between two different impact energy levels (circle = 2.5 J,
square = 5 J, triangle = control). B illustrates the viability when treated
post-impact with NAC (48 hours post-2.5 J).
Figure 2. Impact-induced ROS production in osteochondral explants.
The images show Z-axis reconstructions of DHE-stained chondrocytes
(bright red nuclei) in impacted cartilage (A,B,C) and in adjacent non-
impacted cartilage (D,E,F) at 30 minutes (A,D), at 60 minutes (B,E),
and at 2 hours (C,F) post-injury. The bar in A is 100 mm long. (G) Low
magniﬁcation imaging (bar = 1mm) revealed heavy accumulation of DHE-
stained chondrocytes within and closely adjacent to the border of the
circular impact site (arrows) at 2 hours post impact.
Figure 3. The NOX inhibitor apocynin inhibits impact-induced chondro-
cyte death. Explants cultured with or without apocynin for 3 days were
subjected to a 2.5 J impact (Impact). A set of controls were cultured for
3 days but were not impacted (Non-Impact). Columns and error bars
show means and standard deviations based on 3 explants. The bar and
asterisk indicate a signiﬁcant difference between apocynin-threated and
control.
